Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -30.00 (-2.38%)
Bid:
1,232.00
Ask:
1,246.00
Spread: 14.00 (1.136%)
Market Cap: £239.12m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Result of AGM

18 Jul 2024 16:48

The Biotech Growth Trust PLC - Result of AGM

The Biotech Growth Trust PLC - Result of AGM

PR Newswire

LONDON, United Kingdom, July 18

THE BIOTECH GROWTH TRUST PLC

(the "Company")

 

Results of the Annual General Meeting

 

The Board is pleased to announce that at the Annual General Meeting (AGM) of the Company held on Thursday, 18 July 2024 all resolutions as detailed below were duly passed by shareholders on a poll.

 

Resolutions

Votes For

%

Votes Against

%

Total Votes Cast

Votes

Withheld*

 

1. To receive the audited financial statements and the Report of the Directors for the year ended 31 March 2024.

 

9,341,023

99.97

2,814

0.03

9,343,837

1,848

2. To approve the Directors' Remuneration Report for the year ended 31 March 2024.

 

9,297,309

99.58

39,122

0.42

9,336,431

9,254

3. To elect Hamish Baillie as a Director of the Company.

 

9,326,509

99.85

14,088

0.15

9,340,597

5,088

4. To re-elect Geoff Hsu as a Director of the Company.

 

9,324,487

99.83

16,110

0.17

9,340,597

5,088

5. To re-elect Julia Le Blan as a Director of the Company.

 

9,092,656

97.35

247,840

2.65

9,340,496

5,188

6. To re-elect Dr Nicki Shepherd as a Director of the Company.

 

9,096,040

97.38

244,456

2.62

9,340,496

5,188

7. To re-elect The Rt Hon Lord Willetts as a Director of the Company.

 

9,049,367

96.89

290,754

3.11

9,340,121

5,563

8. To re-elect Roger Yates as a Director of the Company.

 

8,825,220

94.48

515,276

5.52

9,340,496

5,188

9. To re-appoint BDO LLP as auditor and to authorise the Audit Committee to determine their remuneration.

 

8,257,243

99.88

9,687

0.12

8,266,930

1,078,755

10. To authorise the Directors to allot securities in the Company.

 

9,321,581

99.79

19,686

0.21

9,341,267

4,418

11#. To disapply the rights of pre-emption in relation to the allotment of securities.

 

9,306,351

99.62

35,636

0.38

9,341,987

3,698

12#. To authorise the Company to make market purchases of Ordinary shares in the Company.

 

9,333,066

99.93

6,671

0.07

9,339,737

5,948

13#. That the Directors be permitted to hold General Meetings (excluding the AGM) on not less than 14 clear days' notice.

 

9,311,567

99.66

31,809

0.34

9,343,376

2,309

 

# - Special Resolution

 

* Please note that a `vote withheld' is not a vote in law and is not counted in the calculation of the proportion of votes `For' and `Against' a resolution.

 

Any proxy votes which are at the discretion of the Chairman have been included in the "For" total.

 

At the date of the AGM, the total number of Ordinary shares of 25p each in issue and the total number of voting rights was 32,887,198.

 

The proxy voting figures will shortly also be available on the Company's website at www.biotechgt.com

In accordance with Listing Rule 9.6.2, the full text of the resolutions passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Resolutions 10 to 13 will additionally be filed at Companies House.

 

18 July 2024

 

For further information please contact:

 

Katherine Manson

Frostrow Capital LLP - Company Secretary

020 3709 8734

 



Date   Source Headline
19th Feb 202612:32 pmPRNNet Asset Value(s)
18th Feb 202612:15 pmPRNNet Asset Value(s)
17th Feb 202612:04 pmPRNNet Asset Value(s)
16th Feb 20261:36 pmPRNNet Asset Value(s)
13th Feb 20265:18 pmPRNTransaction in Own Shares
13th Feb 20263:33 pmPRNNet Asset Value(s)
12th Feb 202612:24 pmPRNNet Asset Value(s)
12th Feb 202612:03 pmPRNMonthly Fact Sheet as at 31 January 2026
11th Feb 20261:44 pmPRNNet Asset Value(s)
11th Feb 202611:00 amPRNInvestor Presentation via Investor Meet Company
10th Feb 20261:07 pmPRNNet Asset Value(s)
9th Feb 20261:18 pmPRNNet Asset Value(s)
6th Feb 20265:18 pmPRNTransaction in Own Shares
6th Feb 20262:47 pmPRNNet Asset Value(s)
5th Feb 20261:16 pmPRNNet Asset Value(s)
4th Feb 20261:45 pmPRNNet Asset Value(s)
3rd Feb 20261:07 pmPRNNet Asset Value(s)
2nd Feb 20262:51 pmPRNNet Asset Value(s)
2nd Feb 202610:31 amPRNTotal Voting Rights
30th Jan 20265:19 pmPRNTransaction in Own Shares
30th Jan 20262:21 pmPRNNet Asset Value(s)
29th Jan 20262:59 pmPRNNet Asset Value(s)
28th Jan 202612:52 pmPRNNet Asset Value(s)
27th Jan 20261:06 pmPRNNet Asset Value(s)
26th Jan 202612:30 pmPRNNet Asset Value(s)
23rd Jan 20265:33 pmPRNTransaction in Own Shares
23rd Jan 20262:25 pmPRNNet Asset Value(s)
22nd Jan 202612:39 pmPRNNet Asset Value(s)
21st Jan 20262:37 pmPRNNet Asset Value(s)
20th Jan 202612:23 pmPRNNet Asset Value(s)
19th Jan 20261:32 pmPRNNet Asset Value(s)
16th Jan 20265:08 pmPRNTransaction in Own Shares
16th Jan 20262:20 pmPRNNet Asset Value(s)
15th Jan 20262:39 pmPRNNet Asset Value(s)
15th Jan 20262:32 pmPRNMonthly Fact Sheet as at 31 December 2025
14th Jan 20261:18 pmPRNNet Asset Value(s)
13th Jan 202612:33 pmPRNNet Asset Value(s)
12th Jan 20261:10 pmPRNNet Asset Value(s)
9th Jan 20265:20 pmPRNTransaction in Own Shares
9th Jan 20262:15 pmPRNNet Asset Value(s)
8th Jan 20261:01 pmPRNNet Asset Value(s)
7th Jan 20261:14 pmPRNNet Asset Value(s)
6th Jan 20261:12 pmPRNNet Asset Value(s)
5th Jan 20261:06 pmPRNNet Asset Value(s)
2nd Jan 20261:48 pmPRNNet Asset Value(s)
2nd Jan 202610:37 amPRNTotal Voting Rights
31st Dec 202512:13 pmPRNNet Asset Value(s)
30th Dec 20255:18 pmRNSTransaction in Own Shares
30th Dec 20255:18 pmPRNTransaction in Own Shares
30th Dec 20251:33 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.